Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

Successful Treatment of an Aggressive Tracheal Malignancy With Immunotherapy.

Osho AA, Azzoli CJ, Pai S, Mino-Kenudson M, Faquin WC, Huynh TG, Lanuti M, Mathisen DJ, Muniappan A.

Ann Thorac Surg. 2017 Feb;103(2):e123-e125. doi: 10.1016/j.athoracsur.2016.08.021.

PMID:
28109369
2.

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.

Nakagawa S, Wei L, Song WM, Higashi T, Ghoshal S, Kim RS, Bian CB, Yamada S, Sun X, Venkatesh A, Goossens N, Bain G, Lauwers GY, Koh AP, El-Abtah M, Ahmad NB, Hoshida H, Erstad DJ, Gunasekaran G, Lee Y, Yu ML, Chuang WL, Dai CY, Kobayashi M, Kumada H, Beppu T, Baba H, Mahajan M, Nair VD, Lanuti M, Villanueva A, Sangiovanni A, Iavarone M, Colombo M, Llovet JM, Subramanian A, Tager AM, Friedman SL, Baumert TF, Schwarz ME, Chung RT, Tanabe KK, Zhang B, Fuchs BC, Hoshida Y; Precision Liver Cancer Prevention Consortium..

Cancer Cell. 2016 Dec 12;30(6):879-890. doi: 10.1016/j.ccell.2016.11.004.

PMID:
27960085
3.

Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases.

Uruga H, Bozkurtlar E, Huynh TG, Muzikansky A, Goto Y, Gomez-Caraballo M, Hata AN, Gainor JF, Mark EJ, Engelman JA, Lanuti MD, Mino-Kenudson M.

J Thorac Oncol. 2017 Mar;12(3):458-466. doi: 10.1016/j.jtho.2016.10.015.

PMID:
27815126
4.

Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment.

Huynh TG, Morales-Oyarvide V, Campo MJ, Gainor JF, Bozkurtlar E, Uruga H, Zhao L, Gomez-Caraballo M, Hata AN, Mark EJ, Lanuti M, Engelman JA, Mino-Kenudson M.

J Thorac Oncol. 2016 Nov;11(11):1869-1878. doi: 10.1016/j.jtho.2016.08.134.

PMID:
27568346
5.

Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.

Chiurchiù V, Rapino C, Talamonti E, Leuti A, Lanuti M, Gueniche A, Jourdain R, Breton L, Maccarrone M.

J Immunol. 2016 Nov 1;197(9):3545-3553.

PMID:
27694494
6.

Managing Controversial Issues in Thoracic Surgery.

Lanuti M.

Thorac Surg Clin. 2016 Aug;26(3):ix. doi: 10.1016/j.thorsurg.2016.05.001. No abstract available.

PMID:
27427531
7.

Surgical Management of Oligometastatic Non-Small Cell Lung Cancer.

Lanuti M.

Thorac Surg Clin. 2016 Aug;26(3):287-94. doi: 10.1016/j.thorsurg.2016.04.002. Review.

PMID:
27427523
8.

NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.

Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling T, Dobelbower M, Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Sharma N, Swanson SJ, Stevenson J, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2016 Jul;14(7):825-36.

PMID:
27407123
9.

Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.

Catanzaro G, Pucci M, Viscomi MT, Lanuti M, Feole M, Angeletti S, Grasselli G, Mandolesi G, Bari M, Centonze D, D'Addario C, Maccarrone M.

J Neuroimmunol. 2016 May 15;294:32-40. doi: 10.1016/j.jneuroim.2016.03.009.

PMID:
27138096
10.

Feasibility of a procedure does not always translate to what is most efficacious.

Lanuti M.

J Thorac Cardiovasc Surg. 2016 Jun;151(6):e109. doi: 10.1016/j.jtcvs.2016.03.004. No abstract available.

PMID:
27016791
11.

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.

Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower MC, Govindan R, Hennon M, Horn L, Jahan TM, Komaki R, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Sharma N, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2016 Mar;14(3):255-64.

PMID:
26957612
12.

Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.

DePeralta DK, Wei L, Ghoshal S, Schmidt B, Lauwers GY, Lanuti M, Chung RT, Tanabe KK, Fuchs BC.

Cancer. 2016 Apr 15;122(8):1216-27. doi: 10.1002/cncr.29912.

PMID:
26914713
13.

Impact of Nonvascular Thoracic MR Imaging on the Clinical Decision Making of Thoracic Surgeons: A 2-year Prospective Study.

Ackman JB, Gaissert HA, Lanuti M, Digumarthy SR, Shepard JA, Halpern EF, Wright CD.

Radiology. 2016 Aug;280(2):464-74. doi: 10.1148/radiol.2016152004.

PMID:
26909650
14.

Percutaneous CT guided lung biopsy in patients with pulmonary hypertension: Assessment of complications.

Digumarthy SR, Kovacina B, Otrakji A, Lanuti M, Shepard JA, Sharma A.

Eur J Radiol. 2016 Feb;85(2):466-71. doi: 10.1016/j.ejrad.2015.12.007.

PMID:
26781153
15.

Prospective Clinical Study to Evaluate Clinical Performance of a Powered Surgical Stapler in Video-assisted Thoracoscopic Lung Resections.

Licht PB, Ribaric G, Crabtree T, Lanuti M, Molins L, Knippenberg S, Schwiers M, Yoo A.

Surg Technol Int. 2015 Nov;27:67-75.

PMID:
26680381
16.

Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.

Tapias LF, Mathisen DJ, Wright CD, Wain JC, Gaissert HA, Muniappan A, Lanuti M, Donahue DM, Morse CR.

Ann Thorac Surg. 2016 Mar;101(3):1097-103. doi: 10.1016/j.athoracsur.2015.09.062.

PMID:
26652140
17.

Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition.

Schmidt B, Wei L, DePeralta DK, Hoshida Y, Tan PS, Sun X, Sventek JP, Lanuti M, Tanabe KK, Fuchs BC.

Int J Cancer. 2016 Mar 15;138(6):1494-505. doi: 10.1002/ijc.29893.

18.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy.

Zhou H, Tapias LF, Gaissert HA, Muniappan A, Wright CD, Wain JC, Donahue DM, Morse CR, Mathisen DJ, Lanuti M.

Ann Thorac Surg. 2015 Sep;100(3):910-6. doi: 10.1016/j.athoracsur.2015.04.034.

PMID:
26165483
19.

Assessment of Proliferation and Cytotoxicity in a Biomimetic Three-Dimensional Model of Lung Cancer.

Tapias LF, Gilpin SE, Ren X, Wei L, Fuchs BC, Tanabe KK, Lanuti M, Ott HC.

Ann Thorac Surg. 2015 Aug;100(2):414-21. doi: 10.1016/j.athoracsur.2015.04.035.

PMID:
26141774
20.

Better Prognostic Models May Result in Improved Patient Selection for Adjuvant Therapies After Complete Resection of Solitary Fibrous Tumors of the Pleura.

Tapias LF, Lanuti M.

J Thorac Oncol. 2015 Jul;10(7):e61. doi: 10.1097/JTO.0000000000000556. No abstract available.

Supplemental Content

Loading ...
Support Center